Your browser doesn't support javascript.
loading
RNF19A-mediated ubiquitination of BARD1 prevents BRCA1/BARD1-dependent homologous recombination.
Zhu, Qian; Huang, Jinzhou; Huang, Hongyang; Li, Huan; Yi, Peiqiang; Kloeber, Jake A; Yuan, Jian; Chen, Yuping; Deng, Min; Luo, Kuntian; Gao, Ming; Guo, Guijie; Tu, Xinyi; Yin, Ping; Zhang, Yong; Su, Jun; Chen, Jiayi; Lou, Zhenkun.
Afiliación
  • Zhu Q; Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
  • Huang J; Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
  • Huang H; Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
  • Li H; Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, 999077, China.
  • Yi P; Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
  • Kloeber JA; Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
  • Yuan J; Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
  • Chen Y; Mayo Clinic Medical Scientist Training Program, Mayo Clinic, Rochester, MN, 55905, USA.
  • Deng M; Research Center for Translational Medicine, East Hospital, Tongji University School of medicine, Shanghai, 200120, China.
  • Luo K; Research Center for Translational Medicine, East Hospital, Tongji University School of medicine, Shanghai, 200120, China.
  • Gao M; Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
  • Guo G; Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
  • Tu X; Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
  • Yin P; Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
  • Zhang Y; Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
  • Su J; Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
  • Chen J; Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
  • Lou Z; Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
Nat Commun ; 12(1): 6653, 2021 11 17.
Article en En | MEDLINE | ID: mdl-34789768
BRCA1-BARD1 heterodimers act in multiple steps during homologous recombination (HR) to ensure the prompt repair of DNA double strand breaks. Dysfunction of the BRCA1 pathway enhances the therapeutic efficiency of poly-(ADP-ribose) polymerase inhibitors (PARPi) in cancers, but the molecular mechanisms underlying this sensitization to PARPi are not fully understood. Here, we show that cancer cell sensitivity to PARPi is promoted by the ring between ring fingers (RBR) protein RNF19A. We demonstrate that RNF19A suppresses HR by ubiquitinating BARD1, which leads to dissociation of BRCA1-BARD1 complex and exposure of a nuclear export sequence in BARD1 that is otherwise masked by BRCA1, resulting in the export of BARD1 to the cytoplasm. We provide evidence that high RNF19A expression in breast cancer compromises HR and increases sensitivity to PARPi. We propose that RNF19A modulates the cancer cell response to PARPi by negatively regulating the BRCA1-BARD1 complex and inhibiting HR-mediated DNA repair.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteína BRCA1 / Proteínas Supresoras de Tumor / Ubiquitina-Proteína Ligasas / Ubiquitinación / Recombinación Homóloga Límite: Female / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteína BRCA1 / Proteínas Supresoras de Tumor / Ubiquitina-Proteína Ligasas / Ubiquitinación / Recombinación Homóloga Límite: Female / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2021 Tipo del documento: Article País de afiliación: China